Entering text into the input field will update the search result below

Coloplast A/S's (CLPBF) CEO Kristian Villumsen on Q4 2021 Results - Earnings Call Transcript

Nov. 01, 2021 4:48 PM ETColoplast A/S (CLPBF), CLPBY
SA Transcripts profile picture
SA Transcripts

Coloplast A/S (OTCPK:CLPBF) Q4 2021 Earnings Conference Call November 1, 2021 10:00 AM ET

Company Participants

Kristian Villumsen - President & Chief Executive Officer

Anders Lonning-Skovgaard - Chief Financial Officer

Conference Call Participants

Patrick Wood - Bank of America Merrill Lynch

Lisa Bedell Clive - Bernstein

Martin Parkhøi - Danske Bank

Hassan Al-Wakeel - Barclays Investment Bank

Veronika Dubajova - Goldman Sachs

Christian Sørup Ryom - Nordea Markets

Maja Pataki - Kepler Cheuvreux SA

Niels Granholm-Leth - Carnegie Investment Bank AB

Mattias Häggblom - Handelsbanken

Yiwei Zhou - Skandinaviska Enskilda Banken AB


Welcome to the Coloplast Full Year Financial Results 2020/21 Conference Call. Throughout the call, all participants will be in listen-only mode, and afterwards there’ll be a question-and-answer session.

Today, I am pleased to present Kristian Villumsen, President and CEO; and Anders Lonning-Skovgaard, Executive Vice President and CFO. Please begin your meeting.

Kristian Villumsen

Thank you, operator, and welcome, everybody. Good afternoon and welcome to our full year 2021 conference call.

I’m Kristian Villumsen, CEO of Coloplast and I’m joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We are going to start with a short presentation by Anders and myself, and then open up for questions like we usually do. Please turn to Slide number 3.

I’m very satisfied with this year’s results. We delivered 7% organic growth, a 33% EBIT margin before special items and a return on invested capital of 45% after tax and before special items. Broadly, across all markets, we continue to take market share.

In Q4, we delivered 10% organic growth and a 32% EBIT margin. These are filed numbers in a year, where our growth within Chronic Care has been challenged by the pandemic.

At Coloplast, we are united around a strong purpose, to make life easier for people with intimate

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!


SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CLPBF

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.